This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Enterococcus faecium
- DrugBank Accession Number
- DB14225
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Enterococcus faecium whole
- Streptococcus faecium whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Adjunct therapy in treatment of Dyspepsia ••• ••• •••••••• •••••••• Adjunct therapy in treatment of Enteritis ••• ••• •••••••• •••••••• Adjunct therapy in treatment of Enterocolitis ••• ••• •••••••• •••••••• Adjunct therapy in treatment of Intestinal bacteria flora disturbance ••• ••• •••••••• •••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Mogut Enterococcus faecium (20 g/100mL) + Lactobacillus reuteri (20 g/100mL) Liquid Oral Coenbio Co., Ltd. 2017-08-01 Not applicable US 
- Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Mogut Enterococcus faecium (20 g/100mL) + Lactobacillus reuteri (20 g/100mL) Liquid Oral Coenbio Co., Ltd. 2017-08-01 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 34YYS7G16P
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 1943794
- Wikipedia
- Enterococcus_faecium
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Unknown Status Treatment Gut -Microbiota / Irritable Bowel Syndrome (IBS) 1 3 Not Yet Recruiting Supportive Care Amyloidosis, Immunoglobulin Light-chain 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral 75000000 units Liquid Oral Capsule Oral Solution / drops Oral 30000000 cells - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 04, 2018 22:49 / Updated at June 12, 2020 16:53